Home
Boehringer Ingelheim

Boehringer Ingelheim Market Share Analysis for November 2025

C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one.

Health > Biotechnology and Pharmaceuticals

Domainboehringer-ingelheim.fr

Year Founded1885

Employees> 10001

Annual Revenue> $1B

Boehringer Ingelheim

Boehringer Ingelheim (including company regionals)

boehringer-ingelheim.fr

See more website traffic and engagement information

Boehringer Ingelheim Revenue up to November 2025 is > 1B

revenue generated by Boehringer Ingelheim top domains

Boehringer Ingelheim top domains revenue over 3 years

Revenue for Boehringer Ingelheim top domains

boehringer-ingelheim.fr> 1B

See more with Sales Intelligence

Total visits to Boehringer Ingelheim's top domains

Understand Boehringer Ingelheim market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Boehringer Ingelheim's top domains

Analyze Boehringer Ingelheim engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Boehringer Ingelheim's top domains

See how Boehringer Ingelheim keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Boehringer Ingelheim top competitors by domain

Top similar sites in November 2025, ranked by their affinity

bmsfrance.frCompany NameGlobal Biopharmaceutical Company - Br...Employees501 - 1000HQFranceAnnual revenue--Total visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Boehringer Ingelheim

These are the website technologies, by industry, used by Boehringer Ingelheim top domains

Conversion & Analytics (6)

Google Analytics

Social (4)

Google+ Platform

Payment & Currencies (3)

Euro

Content Management System (2)

Drupal

More Technologies

6

See all

News & Signals from Boehringer Ingelheim

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNotogen Inc. partners with Boehringer Ingelheim.In January 2023, In order to develop and market a Notogen regenerative therapeutic that has the potential to be a first-in-class, disease-modifying treatment for people with degenerative disc disease (DDD), Notogen, Inc. recently announced that it had entered a worldwide research collaboration and licence agreement with Boehringer Ingelheim.

NewsBoehringer Ingelheim partners with MabGenesis Inc.Furthermore, Boehringer Ingelheim, a Germany-based research-driven pharmaceutical company, announced a collaboration with MabGenesis, Inc., a Japan-based biopharmaceutical company pioneering in the development of therapeutic monoclonal antibody drugs for the treatment of human diseases.